MarketPulse
R

$RIGL

1 article found
1 positive
0 negative
0 neutral
BenzingaBenzinga··Vandana Singh

Rigel Pharmaceuticals Secures Breast Cancer Drug Rights in Major Pfizer-Arvinas Deal

Rigel Pharmaceuticals licenses FDA-approved breast cancer drug VEPPANU from Arvinas and Pfizer, committing $40M to development and commercialization rights.
PFEARVNRIGLFDA approvalbreast cancer